Celexocib (200 Mg/d) or Diclofenac (100 Mg/d) in Osteoarthritis: A Multicentre, Double Blind Trial

Basit Öğe Kaydı
dc.contributor.authorYazıcı, Hilmi
dc.contributor.authorÖzdemir, O.
dc.contributor.authorKirazlı, Y.
dc.contributor.authorÖzbek, S.
dc.contributor.authorÖzerbil, O.
dc.contributor.authorGür, A.
dc.contributor.authorArdıçoğlu, O.
dc.date.accessioned2020-03-26T16:45:29Z
dc.date.available2020-03-26T16:45:29Z
dc.date.issued2003
dc.departmentSelçuk Üniversitesien_US
dc.descriptionAnnual European Congress of Rheumatology -- 37790 -- Lisbon, Portugalen_US
dc.description.abstract[Abstract not Available]en_US
dc.identifier.citationYazıcı, H., Özdemir, O., Kirazlı, Y., Özbek, S., Özerbil, O., Gür, A., Ardıçoğlu, O., (2003). Celexocib (200 Mg/d) or Diclofenac (100 Mg/d) in Osteoarthritis: A Multicentre, Double Blind Trial. Annals of the Rheumatic Diseases, (62), 260-260.
dc.identifier.endpage260en_US
dc.identifier.issn0003-4967en_US
dc.identifier.startpage260en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12395/18388
dc.identifier.volume62en_US
dc.identifier.wosWOS:000224551400849en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.institutionauthorYazıcı, Hilmi
dc.language.isoenen_US
dc.publisherB M J Publishing Groupen_US
dc.relation.ispartofAnnals of the Rheumatic Diseasesen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.titleCelexocib (200 Mg/d) or Diclofenac (100 Mg/d) in Osteoarthritis: A Multicentre, Double Blind Trialen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Sahne Sanatları Koleksiyonu